The earnings call is a routine event where PDS Biotechnology Corporation discusses its quarterly financial results and updates on clinical strategies. This information is crucial for investors to assess the company's performance and future prospects. However, without specific details on financial performance or strategic changes, the immediate impact on stock price is neutral.